Everything to know about the couples leading Netflix's latest, Blue Therapy.

BPL‑003 holds Breakthrough Therapy Designation and is supported by positive Phase 2b results in treatment-resistant depressionCash runway ...

About NKGen Biotech NKGen is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous and allogeneic NK cell therapeutics. NKGen is ...

Webinar will include a review of full-year 2025 and fourth quarter 2025 financial results, a deep dive into the equine veterinary market and Zomedica's equine-focused product portfolio, along with a ...

LifeMD, Inc. ( LFMD) Q4 2025 Earnings Call March 9, 2026 4:30 PM EDT ...

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative ...

Q4 2025 Earnings Call March 9, 2026 4:30 PM EDTCompany ParticipantsNichol Ochsner - Vice President of Investor ...

Explore current research on hoarding prevalence and its implications. Understand the insights that shape our view on hoarding behaviors today. Don't miss out!

Earnings call ADCT’s Q4 2025 saw ZYNLONTA net product revenue rise to $22.3M (up from $16.4M YoY), with full-year sales at $73.6M, broadly stable versus 2024. Operating expenses were cut by 15% in Q4, ...

Kwanti, a leading portfolio analytics solution aiding financial advisors and investment managers with prospect conversion, client retention, model management, proposal generation, and more, today ...

"As we prepare to commence the Phase1/2 FUNCTION-DMD clinical trial for PBGENE-DMD, we're excited to present new preclinical data highlighting its potential to deliver durable, long-term functional ...